PPARA and Parkinson disease: Barbiero et al. also demonstrated that PPARα and PPARγ agonists had protective effects in a similar animal model of Parkinson's disease, preserving locomotor and cognitive activity and preventing loss and dysfunction of dopaminergic neurons [58].